Vaishali Pharma Limited has informed the Exchange about Copy of Newspaper Publication
VAISHALI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vaishali Pharma Limited has informed the NSE that it published its unaudited financial results for the quarter ended 30 June 2025 in newspapers, as required by SEBI listing rules. The Board of Directors had approved these Q1 results at a meeting held on 11 August 2025 at the company's registered office in Borivali West, Mumbai. The results were advertised in 'The Active Time' (English) and 'Mumbai Lakshdeep' (Marathi) on 13 August 2025. The filing is being made under Regulation 30 read with Regulation 47 of the SEBI (LODR) Regulations, 2015. The specific Q1 financial numbers for Vaishali Pharma are not included in this particular filing, which is purely a compliance confirmation of the newspaper publication step.
This is a routine regulatory compliance disclosure that simply confirms the company's Q1 results were published in newspapers as mandated. It carries no new financial information beyond what was already approved by the Board, so there is no direct material impact on shareholders or the stock price from this filing alone.